2nd Oct 2020 11:40
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 01 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,328,924 | 1.81% | 464,904 | 0.36% | ||
(2) | Derivatives (other than options): | ||||
355,000 | 0.28% | 388,524 | 0.30% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
| TOTAL: | |||||
2,683,924 | 2.08% | 853,428 | 0.66% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 208.6700 USD |
Purchase | 17 | 209.4000 USD |
Purchase | 24 | 208.5650 USD |
Purchase | 28 | 207.9000 USD |
Purchase | 50 | 208.9200 USD |
Purchase | 100 | 207.8500 USD |
Purchase | 100 | 209.9500 USD |
Purchase | 108 | 208.7577 USD |
Purchase | 142 | 208.7478 USD |
Purchase | 327 | 208.7248 USD |
Purchase | 412 | 208.8707 USD |
Purchase | 601 | 209.2954 USD |
Purchase | 800 | 208.9362 USD |
Purchase | 823 | 208.8512 USD |
Purchase | 1,024 | 209.1161 USD |
Purchase | 1,206 | 208.7601 USD |
Purchase | 1,345 | 208.8209 USD |
Purchase | 1,409 | 208.6214 USD |
Purchase | 2,064 | 209.3812 USD |
Purchase | 3,900 | 208.7157 USD |
Purchase | 3,967 | 210.0800 USD |
Purchase | 5,675 | 208.8802 USD |
Purchase | 9,393 | 209.4995 USD |
Purchase | 13,478 | 208.9609 USD |
Purchase | 13,745 | 209.4825 USD |
Purchase | 15,000 | 208.9500 USD |
Purchase | 15,800 | 208.9493 USD |
Purchase | 20,215 | 208.2500 USD |
Purchase | 27,884 | 210.0667 USD |
Purchase | 51,215 | 208.6815 USD |
Sale | 4 | 207.8500 USD |
Sale | 28 | 207.9000 USD |
Sale | 32 | 208.7921 USD |
Sale | 50 | 208.5000 USD |
Sale | 58 | 208.8396 USD |
Sale | 74 | 208.8748 USD |
Sale | 80 | 208.8354 USD |
Sale | 93 | 208.4451 USD |
Sale | 96 | 208.7610 USD |
Sale | 100 | 207.8400 USD |
Sale | 101 | 209.2657 USD |
Sale | 105 | 208.8488 USD |
Sale | 126 | 208.9386 USD |
Sale | 149 | 207.8892 USD |
Sale | 150 | 208.2566 USD |
Sale | 185 | 208.2100 USD |
Sale | 200 | 209.3150 USD |
Sale | 203 | 208.8990 USD |
Sale | 285 | 210.0700 USD |
Sale | 300 | 209.6400 USD |
Sale | 300 | 208.7466 USD |
Sale | 300 | 209.2933 USD |
Sale | 323 | 208.8452 USD |
Sale | 399 | 208.9060 USD |
Sale | 428 | 209.2032 USD |
Sale | 800 | 208.9363 USD |
Sale | 830 | 208.9037 USD |
Sale | 1,103 | 208.8875 USD |
Sale | 1,357 | 208.6415 USD |
Sale | 1,781 | 209.4883 USD |
Sale | 2,250 | 208.8886 USD |
Sale | 2,524 | 209.1212 USD |
Sale | 4,492 | 210.0800 USD |
Sale | 5,675 | 208.8802 USD |
Sale | 9,631 | 209.2114 USD |
Sale | 12,488 | 209.7382 USD |
Sale | 12,526 | 208.9724 USD |
Sale | 15,000 | 208.9500 USD |
Sale | 15,800 | 208.9493 USD |
Sale | 27,847 | 210.0653 USD |
Sale | 30,211 | 208.4241 USD |
Sale | 42,832 | 208.6327 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 2 Oct 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20201002005217/en/
Copyright Business Wire 2020
Related Shares:
Barclays